Agios Stock Down Year: Why It Fell 16% and What Next
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
For beginners, compare index funds and mutual funds on cost, simplicity, and diversification to choose the easier path to investing.
24,324 articlesBiotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
Bitcoin steadies near $65,000 as traders weigh a potential bottom formation and hedging demand spikes, aided by spot ...
President Donald Trump steps back into the crypto policy debate, accusing banks of blocking progress on GENIUS Act an...
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
A newly released Justice Department file details how Jeffrey Epstein financed a Gates-connected ex-girlfriend for yea...
Insider trades can hint at a company's future, but not every move is meaningful. This article shows how to filter sig...
Morgan Stanley reports record revenue for 2025 and a solid Q4, but shares fall as liquidity constraints in private ma...
With markets volatile in May 2026, delaying Social Security to age 70 can raise lifetime benefits. The breakeven poin...
Oil’s sharp moves in early 2026 push investors toward stock-based plays that mimic commodity exposure without futures...
Ethereum faces renewed selling pressure after a failed attempt to reclaim key resistance. As the week unfolds, trader...
A late-stage planning window lets a 67-year-old solo 401(k) holder convert pre-tax balances to Roth, tapping substant...
Could a single crypto asset multiply your wealth over 10 years? This article lays out a practical, data-driven look a...